Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun;26(6):881-893.
doi: 10.1038/s41590-025-02152-4. Epub 2025 May 21.

Cholinergic regulation of thymocyte negative selection

Affiliations

Cholinergic regulation of thymocyte negative selection

Shaofeng Liu et al. Nat Immunol. 2025 Jun.

Abstract

The immune and nervous systems use a common chemical language for communication, namely, the cholinergic signaling involving acetylcholine (ACh) and its receptors (AChRs). Whether and how this language also regulates the development of the immune system is poorly understood. Here, we show that mouse CD4+CD8+ double-positive thymocytes express high levels of α9 nicotinic AChR (nAChR) and that this receptor controls thymic negative selection. α9 nAChR-deficient mice show an altered T cell receptor (TCR) repertoire and reduced CD4+ and CD8+ T cells in a mixed bone marrow chimera setting. α9 nAChR-mediated signaling regulates TCR strength and thymocyte survival. Thymic tuft cells, B cells and some T cells express choline acetyltransferase and are potential ACh sources, with ACh derived from T cells having the most important role. Furthermore, α9 nAChR deficiency during thymocyte development contributes to the altered development of autoimmune diseases in mice. Our results thus reveal a mechanism controlling immune cell development that involves cholinergic signaling.

PubMed Disclaimer

Conflict of interest statement

Competing interests: T.W.M. holds equity in Treadwell Therapeutics Inc. and is a consultant for AstraZeneca Inc. H.Q. is a cofounder of Emergent Biomed Solutions, Ltd. P.S.O. is a Scientific Advisory Board member for Providence Therapeutics, Tikva Allocell and Rondo Therapeutics, Inc. P.S.O. also holds a sponsored research agreement with Providence Therapeutics. The other authors declare no competing interests.

References

    1. Picciotto, M. R., Higley, M. J. & Mineur, Y. S. Acetylcholine as a neuromodulator: cholinergic signaling shapes nervous system function and behavior. Neuron 76, 116–129 (2012). - PubMed - PMC - DOI
    1. Cox, M. A. et al. Beyond neurotransmission: acetylcholine in immunity and inflammation. J. Intern. Med. 287, 120–133 (2020). - PubMed - DOI
    1. Wang, H. et al. Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation. Nature 421, 384–388 (2003). - PubMed - DOI
    1. Schloss, M. J. et al. B lymphocyte-derived acetylcholine limits steady-state and emergency hematopoiesis. Nat. Immunol. 23, 605–618 (2022). - PubMed - PMC - DOI
    1. Chu, C. et al. The ChAT-acetylcholine pathway promotes group 2 innate lymphoid cell responses and anti-helminth immunity. Sci. Immunol. 6, eabe3218 (2021). - PubMed - PMC - DOI

MeSH terms

LinkOut - more resources